Immediate versus on-demand oral feeding after emergency caesarean delivery in labour
| ISRCTN | ISRCTN12380398 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN12380398 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | 2021827-10517 |
| Sponsor | University of Malaya |
| Funder | Universiti Malaya |
- Submission date
- 01/10/2021
- Registration date
- 04/10/2021
- Last edited
- 16/02/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Background and study aims
Early food and drink intake after a Caesarean section has positive benefits on early recovery with no complications. The aim of this study is to find out whether immediate feeding or on-demand feeding improves patient satisfaction and to see the overall characteristics of patients' recovery after surgery. This is an important area for future improvement in the management of Caesarean delivery.
Who can participate?
Pregnant women aged 18 – 45 years in labour with no serious medical illnesses who undergo an emergency Caesarean section without complications and no known risk for immediate repeated surgery
What does the study involve?
The participants will be given a sandwich meal and 250 ml drink of their choice upon returning from the operation theatre after delivery, either immediately or on-demand. The postoperative course and maternal satisfaction are assessed before hospital discharge.
What are the possible benefits and risks of participating?
There may or may not be any benefits to participants. Information obtained from this study will help improve standard practice for women undergoing emergency Caesarean section. Early oral intake after surgery is expected to be safe as the guidelines encourage it and based on a recent study the risk of vomiting is low. Patients will be assessed from time to time and allowed for repeated meals and drinks. Patients may have a higher risk of vomiting; those patients will be monitored and medication to prevent and stop vomiting will be given accordingly.
Where is the study run from?
University of Malaya Medical Center (Malaysia)
When is the study starting and how long it is expected to run for?
July 2021 to January 2023
Who is funding the study?
University of Malaya Medical Center (Malaysia)
Who is the main contact?
Dr Nurulhuda binti Ahmad Sani
huda.sani@ummc.edu.my
Contact information
Scientific
University of Malaya Medical Centre, UMMC
Jalan Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia
| 0000-0002-5340-2201 | |
| Phone | +60 (0)3 79492049 |
| huda.sani@ummc.edu.my |
Scientific
University of Malaya Medical Centre, UMMC
Jalan Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia
| 0000-0001-8585-2357 | |
| Phone | +60 (0)3 79492049 |
| jesrine@um.edu.my |
Scientific
University of Malaya Medical Centre
UMMC
Jalan Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia
| Phone | +60 (0)3 79492049 |
|---|---|
| asmahani.as@ummc.edu.my |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Single-centre open-label randomized controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Immediate versus on-demand maternal full feeding after unplanned caesarean section in labour: a randomised trial |
| Study acronym | ImFLUCS |
| Study objectives | Immediate feeding for women after an unplanned caesarean section will increase overall maternal satisfaction but will not increase vomiting. |
| Ethics approval(s) | Approved 22/09/2021, University of Malaya Medical Centre, Kuala Lumpur – Medical Research Ethics Committee (UMMC-MREC, Lembah Pantai, 59100, Kuala Lumpur, Malaysia; +60 (0)379493209; ummc-mrec@ummc.edu.my), ref: MREC ID No: 2021827-10517 |
| Health condition(s) or problem(s) studied | Maternal recovery post unplanned caesarean delivery |
| Intervention | The study will be conducted in the labour suite and postnatal ward at UMMC. The potential participants will receive standard care during labour. Women who consented to participate and undergo emergency caesarean section will be given a sandwich meal and 250 ml drink of their choice upon returning from operation theatre after delivery, either immediately or on-demand. Participants will be randomised into two arms (1:1) via labelled opaque envelopes. Randomisation will be generated by a random sequence generator, provided by random.org. to avoid bias, in blocks of 4 and 8. At this point sealed envelope (intention to treat) which reveals their allocated oral feeding plan, either immediate full feeding or on-demand feeding. The lowest number of the sealed envelope will be taken. A: Sandwich meal and 250 ml drink of their choice given as soon as possible upon returning to labour suite or postnatal ward while the regional anaesthesia still in action. They should consume as much as they can. B: Sandwich meal and 250 ml drink of their choice served on demand. They should consume as much as they can. Post-operative outcomes and maternal satisfaction will be collected prior to discharge. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
Current primary outcome measure as of 18/10/2021: |
| Key secondary outcome measure(s) |
Current secondary outcome measures as of 18/10/2021: |
| Completion date | 16/01/2023 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 45 Years |
| Sex | Female |
| Target sample size at registration | 500 |
| Total final enrolment | 501 |
| Key inclusion criteria | 1. Women in labour (cervical dilatation ≥3 cm, contraction ≥2 in 10 minutes) 2. Age 18 – 45 years 3. Singleton pregnancy 4. Gestation ≥37 weeks 5. Unplanned caesarean section 6. Regional anaesthesia 7. No instruction from the surgeon for postoperative Nil By Mouth (NBM) |
| Key exclusion criteria | 1. Placenta praevia 2. Multiple pregnancy 3. Diabetes requiring insulin therapy 4. Maternal medical problem that requires fluid restriction 5. Patient who is suspected COVID-19 infection or COVID-19 positive 6. Estimated blood loss >1.5 l 7. Additional surgery needed (e.g., myomectomy, cystectomy, bladder or bowel repair) 8. HDU or ICU admission 9. Significant risk of re-laparotomy 10. Appeared distressed and potentially unable to provide informed consent. i.e. in severe pain |
| Date of first enrolment | 18/10/2021 |
| Date of final enrolment | 14/01/2023 |
Locations
Countries of recruitment
- Malaysia
Study participating centre
Kuala Lumpur
59100
Malaysia
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | The datasets generated during and/or analysed during the current study are/will be available upon request from Dr Nurulhuda binti Ahmad Sani (huda.sani@ummc.edu.my, nurul9613@uitm.edu.my). |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | 25/05/2023 | 16/02/2024 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Protocol (other) | 27/08/2021 | 04/10/2021 | No | No |
Editorial Notes
16/02/2024: Publication reference and total final enrolment added.
05/12/2023: The following changes were made to the study record:
1. The recruitment end date was changed from 30/04/2023 to 14/01/2023.
2. The overall study end date was changed from 30/06/2023 to 16/01/2023.
08/11/2022: The recruitment end date was changed from 01/11/2022 to 30/04/2023.
20/06/2022: The contact details were updated and the overall trial end date was changed from 31/12/2022 to 30/06/2023.
18/11/2021: The following changes were made to the trial record:
1. The target number of participants was changed from 528 to 500.
2. The primary and secondary outcome measures were updated.
11/10/2021: The recruitment start date was changed from 11/10/2021 to 18/10/2021.
04/10/2021: Trial's existence confirmed by University of Malaya Medical Centre, Kuala Lumpur – Medical Research Ethics Committee (UMMC-MREC).